Atom Investors LP Avadel Pharmaceuticals PLC Transaction History

Atom Investors LP

  • $906 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$7.34 - $11.18 $556,269 - $847,287
-75,786 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$6.49 - $9.91 $146,037 - $222,994
-22,502 Reduced 22.89%
75,786 $743,000
Q2 2021

Aug 16, 2021
BUY
$6.73 - $9.05 $408,638 - $549,506
60,719 Added 161.62%
98,288 $661,000
Q1 2021

May 17, 2021
BUY
$6.61 - $10.07 $248,331 - $378,319
37,569 New
37,569 $340,000

Others Institutions Holding AVDL

# of Institutions
8
Shares Held
1.07M
Call Options Held
0
Put Options Held
0
View Full List

About AVADEL PHARMACEUTICALS PLC

AVDL Quotes by TradingView
  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $626M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email